JOSEPH TAMARA L
Insider CIK 1433991 · NVIV SVP, General Counsel · MLND General Counsel and Secretary · SPRO Chief Legal Officer · CBST SVP, GC & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | S Sale | 2024-02-02 | 2024-02-05 | 30,906 | $1.37 | $42.3K | 531,615 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-02-01 | 2024-02-05 | 239,731 | — | $0 | 562,521 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-30 | 1,854 | $1.26 | $2.3K | 322,790 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 3,394 | $1.86 | $6.3K | 324,644 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-02-01 | 2023-02-03 | 265,957 | — | $0 | 328,038 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2022-02-01 | 2022-02-03 | 53,190 | — | $0 | 53,190 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-02-01 | 2022-02-03 | 38,014 | — | $0 | 62,081 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2021-08-26 | 2021-08-30 | 24,067 | — | $0 | 24,067 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-12-02 | 2020-12-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-05-25 | 2020-05-27 | 80,000 | — | $0 | 80,000 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2020-01-31 | 2020-02-04 | 56,250 | — | $0 | 56,250 | SEC↗ |
| MLND Millendo Therapeutics, Inc | A Award deriv | 2019-08-19 | 2019-08-20 | 130,000 | — | $0 | 130,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2017-01-18 | 2017-01-20 | 120,000 | — | $0 | 120,000 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2015-12-10 | 2015-12-11 | 92,040 | — | $0 | 92,040 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2015-07-31 | 2015-08-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2014-12-10 | 2014-12-11 | 137,500 | — | $0 | 137,500 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award | 2014-12-10 | 2014-12-11 | 15,428 | — | $0 | 15,428 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2014-03-24 | 2014-03-26 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-06-29 | 2012-07-03 | 640 | $32.22 | $20.6K | 17,571 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-06-06 | 2012-06-08 | 20,000 | — | $0 | 80,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-06-06 | 2012-06-08 | 20,000 | $19.16 | $383.2K | 39,059 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | S Sale | 2012-06-06 | 2012-06-08 | 20,000 | $41.16 | $823.2K | 19,059 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-15 | 2012-05-16 | 1,200 | — | $0 | 1,200 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-15 | 2012-05-16 | 1,200 | — | $0 | 19,059 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-14 | 2012-05-16 | 2,625 | — | $0 | 5,250 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-14 | 2012-05-16 | 2,625 | — | $0 | 17,859 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise deriv | 2012-05-13 | 2012-05-15 | 3,000 | — | $0 | 9,000 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | M Exercise | 2012-05-13 | 2012-05-15 | 3,000 | — | $0 | 15,234 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | J Other | 2012-03-30 | 2012-04-03 | 260 | $43.25 | $11.2K | 12,234 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| CBST CUBIST PHARMACEUTICALS INC | A Award deriv | 2012-02-16 | 2012-02-21 | 6,000 | — | $0 | 6,000 | SEC↗ |